<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CashAndAvailableForSaleSecurities" xlink:href="jazz-20190930.xsd#CashAndAvailableForSaleSecurities" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CashAndAvailableForSaleSecuritiesSummaryOfCashAndCashEquivalentsDetails" xlink:href="jazz-20190930.xsd#CashAndAvailableForSaleSecuritiesSummaryOfCashAndCashEquivalentsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CashAndAvailableForSaleSecuritiesTables" xlink:href="jazz-20190930.xsd#CashAndAvailableForSaleSecuritiesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CertainBalanceSheetItems" xlink:href="jazz-20190930.xsd#CertainBalanceSheetItems" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CertainBalanceSheetItemsAccruedLiabilitiesDetails" xlink:href="jazz-20190930.xsd#CertainBalanceSheetItemsAccruedLiabilitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CertainBalanceSheetItemsPropertyAndEquipmentDetails" xlink:href="jazz-20190930.xsd#CertainBalanceSheetItemsPropertyAndEquipmentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CertainBalanceSheetItemsTables" xlink:href="jazz-20190930.xsd#CertainBalanceSheetItemsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CollaborationAndLicenseAgreementAndAssetAcquisition" xlink:href="jazz-20190930.xsd#CollaborationAndLicenseAgreementAndAssetAcquisition" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CollaborationAndLicenseAgreementAndAssetAcquisitionNarrativeDetails" xlink:href="jazz-20190930.xsd#CollaborationAndLicenseAgreementAndAssetAcquisitionNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CollaborationAndLicenseAgreementAndAssetAcquisitionScheduleOfAssetAcquisitionDetails" xlink:href="jazz-20190930.xsd#CollaborationAndLicenseAgreementAndAssetAcquisitionScheduleOfAssetAcquisitionDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CollaborationAndLicenseAgreementAndAssetAcquisitionTablesTables" xlink:href="jazz-20190930.xsd#CollaborationAndLicenseAgreementAndAssetAcquisitionTablesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CommitmentsAndContingencies" xlink:href="jazz-20190930.xsd#CommitmentsAndContingencies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CommitmentsAndContingenciesNarrativeDetails" xlink:href="jazz-20190930.xsd#CommitmentsAndContingenciesNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CompanyAndSummaryOfSignificantAccountingPolicies" xlink:href="jazz-20190930.xsd#CompanyAndSummaryOfSignificantAccountingPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CompanyAndSummaryOfSignificantAccountingPoliciesAdoptionOfNewAccountingStandardsNarrativeDetails" xlink:href="jazz-20190930.xsd#CompanyAndSummaryOfSignificantAccountingPoliciesAdoptionOfNewAccountingStandardsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CompanyAndSummaryOfSignificantAccountingPoliciesBasisOfPresentationNarrativeDetails" xlink:href="jazz-20190930.xsd#CompanyAndSummaryOfSignificantAccountingPoliciesBasisOfPresentationNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CompanyAndSummaryOfSignificantAccountingPoliciesConcentrationsOfRiskNarrativeDetails" xlink:href="jazz-20190930.xsd#CompanyAndSummaryOfSignificantAccountingPoliciesConcentrationsOfRiskNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CompanyAndSummaryOfSignificantAccountingPoliciesCumulativeEffectOnConsolidatedBalanceSheetDetails" xlink:href="jazz-20190930.xsd#CompanyAndSummaryOfSignificantAccountingPoliciesCumulativeEffectOnConsolidatedBalanceSheetDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CompanyAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:href="jazz-20190930.xsd#CompanyAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CompanyAndSummaryOfSignificantAccountingPoliciesTables" xlink:href="jazz-20190930.xsd#CompanyAndSummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CondensedConsolidatedBalanceSheets" xlink:href="jazz-20190930.xsd#CondensedConsolidatedBalanceSheets" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CondensedConsolidatedStatementsOfCashFlows" xlink:href="jazz-20190930.xsd#CondensedConsolidatedStatementsOfCashFlows" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome" xlink:href="jazz-20190930.xsd#CondensedConsolidatedStatementsOfComprehensiveIncome" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeParenthetical" xlink:href="jazz-20190930.xsd#CondensedConsolidatedStatementsOfComprehensiveIncomeParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CondensedConsolidatedStatementsOfIncome" xlink:href="jazz-20190930.xsd#CondensedConsolidatedStatementsOfIncome" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CondensedConsolidatedStatementsOfShareholdersEquity" xlink:href="jazz-20190930.xsd#CondensedConsolidatedStatementsOfShareholdersEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/Cover" xlink:href="jazz-20190930.xsd#Cover" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/Debt" xlink:href="jazz-20190930.xsd#Debt" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/DebtNarrativeDetails" xlink:href="jazz-20190930.xsd#DebtNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/DebtScheduleOfLongTermDebtDetails" xlink:href="jazz-20190930.xsd#DebtScheduleOfLongTermDebtDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/DebtScheduleOfLongTermDebtDetailsCalc2" xlink:href="jazz-20190930.xsd#DebtScheduleOfLongTermDebtDetailsCalc2" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/DebtScheduleOfMaturitiesOfLongTermDebtDetails" xlink:href="jazz-20190930.xsd#DebtScheduleOfMaturitiesOfLongTermDebtDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/DebtTables" xlink:href="jazz-20190930.xsd#DebtTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/DerivativeInstrumentsAndHedgingActivities" xlink:href="jazz-20190930.xsd#DerivativeInstrumentsAndHedgingActivities" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/DerivativeInstrumentsAndHedgingActivitiesFairValueOfOutstandingDerivativesDetails" xlink:href="jazz-20190930.xsd#DerivativeInstrumentsAndHedgingActivitiesFairValueOfOutstandingDerivativesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/DerivativeInstrumentsAndHedgingActivitiesForeignExchangeGainLossDerivativeInstrumentsDetails" xlink:href="jazz-20190930.xsd#DerivativeInstrumentsAndHedgingActivitiesForeignExchangeGainLossDerivativeInstrumentsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/DerivativeInstrumentsAndHedgingActivitiesGainsOnDerivativeInstrumentsDetails" xlink:href="jazz-20190930.xsd#DerivativeInstrumentsAndHedgingActivitiesGainsOnDerivativeInstrumentsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/DerivativeInstrumentsAndHedgingActivitiesNarrativeDetails" xlink:href="jazz-20190930.xsd#DerivativeInstrumentsAndHedgingActivitiesNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/DerivativeInstrumentsAndHedgingActivitiesOffsettingAssetsAndLiabilitiesDetails" xlink:href="jazz-20190930.xsd#DerivativeInstrumentsAndHedgingActivitiesOffsettingAssetsAndLiabilitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/DerivativeInstrumentsAndHedgingActivitiesTables" xlink:href="jazz-20190930.xsd#DerivativeInstrumentsAndHedgingActivitiesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/FairValueMeasurement" xlink:href="jazz-20190930.xsd#FairValueMeasurement" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/FairValueMeasurementAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" xlink:href="jazz-20190930.xsd#FairValueMeasurementAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/FairValueMeasurementNarrativeDetails" xlink:href="jazz-20190930.xsd#FairValueMeasurementNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/FairValueMeasurementTables" xlink:href="jazz-20190930.xsd#FairValueMeasurementTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/GoodwillAndIntangibleAssets" xlink:href="jazz-20190930.xsd#GoodwillAndIntangibleAssets" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/GoodwillAndIntangibleAssetsEstimatedFutureAmortizationCostsDetails" xlink:href="jazz-20190930.xsd#GoodwillAndIntangibleAssetsEstimatedFutureAmortizationCostsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/GoodwillAndIntangibleAssetsGoodwillActivityDetails" xlink:href="jazz-20190930.xsd#GoodwillAndIntangibleAssetsGoodwillActivityDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/GoodwillAndIntangibleAssetsGrossCarryingAmountsAndNetBookValuesOfIntangibleAssetsDetails" xlink:href="jazz-20190930.xsd#GoodwillAndIntangibleAssetsGrossCarryingAmountsAndNetBookValuesOfIntangibleAssetsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/GoodwillAndIntangibleAssetsGrossCarryingAmountsAndNetBookValuesOfIntangibleAssetsDetailsCalc2" xlink:href="jazz-20190930.xsd#GoodwillAndIntangibleAssetsGrossCarryingAmountsAndNetBookValuesOfIntangibleAssetsDetailsCalc2" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/GoodwillAndIntangibleAssetsNarrativeDetails" xlink:href="jazz-20190930.xsd#GoodwillAndIntangibleAssetsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/GoodwillAndIntangibleAssetsTables" xlink:href="jazz-20190930.xsd#GoodwillAndIntangibleAssetsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/IncomeTaxes" xlink:href="jazz-20190930.xsd#IncomeTaxes" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/IncomeTaxesNarrativeDetails" xlink:href="jazz-20190930.xsd#IncomeTaxesNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/Inventories" xlink:href="jazz-20190930.xsd#Inventories" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/InventoriesComponentsOfInventoriesDetails" xlink:href="jazz-20190930.xsd#InventoriesComponentsOfInventoriesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/InventoriesTables" xlink:href="jazz-20190930.xsd#InventoriesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/Leases" xlink:href="jazz-20190930.xsd#Leases" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/LeasesLeaseCostDetails" xlink:href="jazz-20190930.xsd#LeasesLeaseCostDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" xlink:href="jazz-20190930.xsd#LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetailsCalc2" xlink:href="jazz-20190930.xsd#LeasesMaturitiesOfOperatingLeaseLiabilitiesDetailsCalc2" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:href="jazz-20190930.xsd#LeasesSupplementalBalanceSheetInformationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/LeasesSupplementalCashFlowInformationDetails" xlink:href="jazz-20190930.xsd#LeasesSupplementalCashFlowInformationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/LeasesTables" xlink:href="jazz-20190930.xsd#LeasesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/LeasesWeightedAverageTermsAndDiscountRatesDetails" xlink:href="jazz-20190930.xsd#LeasesWeightedAverageTermsAndDiscountRatesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/NetIncomePerOrdinaryShare" xlink:href="jazz-20190930.xsd#NetIncomePerOrdinaryShare" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/NetIncomePerOrdinaryShareBasicAndDilutedNetIncomeLossPerCommonShareDetails" xlink:href="jazz-20190930.xsd#NetIncomePerOrdinaryShareBasicAndDilutedNetIncomeLossPerCommonShareDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/NetIncomePerOrdinaryShareTables" xlink:href="jazz-20190930.xsd#NetIncomePerOrdinaryShareTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/NetIncomePerOrdinaryShareWeightedAverageOrdinarySharesExcludedFromComputationOfDilutedNetIncomePerShareDetails" xlink:href="jazz-20190930.xsd#NetIncomePerOrdinaryShareWeightedAverageOrdinarySharesExcludedFromComputationOfDilutedNetIncomePerShareDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/Revenues" xlink:href="jazz-20190930.xsd#Revenues" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/RevenuesNarrativeDetails" xlink:href="jazz-20190930.xsd#RevenuesNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/RevenuesSummaryOfContractLiabilitiesDetails" xlink:href="jazz-20190930.xsd#RevenuesSummaryOfContractLiabilitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/RevenuesSummaryOfDisaggregationOfRevenueDetails" xlink:href="jazz-20190930.xsd#RevenuesSummaryOfDisaggregationOfRevenueDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/RevenuesSummaryOfPercentageOfTotalRevenuesFromCustomersDetails" xlink:href="jazz-20190930.xsd#RevenuesSummaryOfPercentageOfTotalRevenuesFromCustomersDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/RevenuesTables" xlink:href="jazz-20190930.xsd#RevenuesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/ShareBasedCompensation" xlink:href="jazz-20190930.xsd#ShareBasedCompensation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/ShareBasedCompensationExpenseDetails" xlink:href="jazz-20190930.xsd#ShareBasedCompensationExpenseDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/ShareBasedCompensationNarrativeDetails" xlink:href="jazz-20190930.xsd#ShareBasedCompensationNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/ShareBasedCompensationRestrictedUnitsDetails" xlink:href="jazz-20190930.xsd#ShareBasedCompensationRestrictedUnitsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/ShareBasedCompensationTables" xlink:href="jazz-20190930.xsd#ShareBasedCompensationTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/ShareBasedCompensationWeightedAverageAssumptionsAndResultingGrantDateFairValueDetails" xlink:href="jazz-20190930.xsd#ShareBasedCompensationWeightedAverageAssumptionsAndResultingGrantDateFairValueDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/ShareholdersEquity" xlink:href="jazz-20190930.xsd#ShareholdersEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/ShareholdersEquityComponentOfAccumulatedOtherComprehensiveLossDetails" xlink:href="jazz-20190930.xsd#ShareholdersEquityComponentOfAccumulatedOtherComprehensiveLossDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/ShareholdersEquityShareRepurchaseProgramsDetails" xlink:href="jazz-20190930.xsd#ShareholdersEquityShareRepurchaseProgramsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/ShareholdersEquityTables" xlink:href="jazz-20190930.xsd#ShareholdersEquityTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/SubsequentEvent" xlink:href="jazz-20190930.xsd#SubsequentEvent" xlink:type="simple" />
  <link:roleRef roleURI="http://www.jazzpharma.com/role/SubsequentEventNarrativeDetails" xlink:href="jazz-20190930.xsd#SubsequentEventNarrativeDetails" xlink:type="simple" />
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/CashAndAvailableForSaleSecurities" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/CashAndAvailableForSaleSecuritiesSummaryOfCashAndCashEquivalentsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_82469E4264065C79B312542B0294C1EA" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_8F1C512B407A5CB590CC83A11FECB29C" xlink:type="locator" />
    <link:calculationArc order="1" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_82469E4264065C79B312542B0294C1EA" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_8F1C512B407A5CB590CC83A11FECB29C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_11768D3F4BD55381BEDFC8EFA1CEF8CC" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_82469E4264065C79B312542B0294C1EA" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_11768D3F4BD55381BEDFC8EFA1CEF8CC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_816C02FC49C65CD59735FA63A3B513DB" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_82469E4264065C79B312542B0294C1EA" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_816C02FC49C65CD59735FA63A3B513DB" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/CashAndAvailableForSaleSecuritiesTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/CertainBalanceSheetItems" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/CertainBalanceSheetItemsAccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_c90cf113-b51b-4312-22d0-4adb9883d309" xlink:type="locator" />
    <link:loc xlink:href="jazz-20190930.xsd#jazz_AccruedRebatesAndOtherSalesDeductions" xlink:label="loc_jazz_AccruedRebatesAndOtherSalesDeductions_53d618f5-227f-3660-28cf-05d64c0057c4" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_c90cf113-b51b-4312-22d0-4adb9883d309" xlink:to="loc_jazz_AccruedRebatesAndOtherSalesDeductions_53d618f5-227f-3660-28cf-05d64c0057c4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedEmployeeBenefitsCurrent" xlink:label="loc_us-gaap_AccruedEmployeeBenefitsCurrent_f46016be-a090-7f0b-44f7-8ddf156c8efc" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_c90cf113-b51b-4312-22d0-4adb9883d309" xlink:to="loc_us-gaap_AccruedEmployeeBenefitsCurrent_f46016be-a090-7f0b-44f7-8ddf156c8efc" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_b91d2f01-85c2-f9fb-3250-26a4b1b39c5e" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_c90cf113-b51b-4312-22d0-4adb9883d309" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_b91d2f01-85c2-f9fb-3250-26a4b1b39c5e" xlink:type="arc" />
    <link:loc xlink:href="jazz-20190930.xsd#jazz_AccruedInventoryRelatedLiabilities" xlink:label="loc_jazz_AccruedInventoryRelatedLiabilities_d802ea00-a28e-ead4-1c45-05d64d395dbd" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_c90cf113-b51b-4312-22d0-4adb9883d309" xlink:to="loc_jazz_AccruedInventoryRelatedLiabilities_d802ea00-a28e-ead4-1c45-05d64d395dbd" xlink:type="arc" />
    <link:loc xlink:href="jazz-20190930.xsd#jazz_AccruedClinicalTrialLiability" xlink:label="loc_jazz_AccruedClinicalTrialLiability_7e078e78-b6c5-b55d-42af-05d64ed2a771" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_c90cf113-b51b-4312-22d0-4adb9883d309" xlink:to="loc_jazz_AccruedClinicalTrialLiability_7e078e78-b6c5-b55d-42af-05d64ed2a771" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedMarketingCostsCurrent" xlink:label="loc_us-gaap_AccruedMarketingCostsCurrent_61b7c309-64a4-994a-2243-5146c70ad44d" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_c90cf113-b51b-4312-22d0-4adb9883d309" xlink:to="loc_us-gaap_AccruedMarketingCostsCurrent_61b7c309-64a4-994a-2243-5146c70ad44d" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedRoyaltiesCurrent" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent_7d4777c3-e41b-9b63-699f-d86dc2fc13b0" xlink:type="locator" />
    <link:calculationArc order="7" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_c90cf113-b51b-4312-22d0-4adb9883d309" xlink:to="loc_us-gaap_AccruedRoyaltiesCurrent_7d4777c3-e41b-9b63-699f-d86dc2fc13b0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_3aae0f17-e5b2-b861-7c74-9a4f42f6d1c8" xlink:type="locator" />
    <link:calculationArc order="8" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_c90cf113-b51b-4312-22d0-4adb9883d309" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_3aae0f17-e5b2-b861-7c74-9a4f42f6d1c8" xlink:type="arc" />
    <link:loc xlink:href="jazz-20190930.xsd#jazz_AccruedConstructionInProgress" xlink:label="loc_jazz_AccruedConstructionInProgress_0089a3f8-a436-b0e1-799d-05d64d0b010a" xlink:type="locator" />
    <link:calculationArc order="9" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_c90cf113-b51b-4312-22d0-4adb9883d309" xlink:to="loc_jazz_AccruedConstructionInProgress_0089a3f8-a436-b0e1-799d-05d64d0b010a" xlink:type="arc" />
    <link:loc xlink:href="jazz-20190930.xsd#jazz_SalesReturnReserve" xlink:label="loc_jazz_SalesReturnReserve_d979b135-e294-092c-1411-05d64effab52" xlink:type="locator" />
    <link:calculationArc order="10" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_c90cf113-b51b-4312-22d0-4adb9883d309" xlink:to="loc_jazz_SalesReturnReserve_d979b135-e294-092c-1411-05d64effab52" xlink:type="arc" />
    <link:loc xlink:href="jazz-20190930.xsd#jazz_AccruedInterest" xlink:label="loc_jazz_AccruedInterest_b29442a4-67ae-39e1-c58f-05d64bf459e7" xlink:type="locator" />
    <link:calculationArc order="11" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_c90cf113-b51b-4312-22d0-4adb9883d309" xlink:to="loc_jazz_AccruedInterest_b29442a4-67ae-39e1-c58f-05d64bf459e7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent_c2051fc9-6e3c-3055-fde4-401ea0dbd57b" xlink:type="locator" />
    <link:calculationArc order="12" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_c90cf113-b51b-4312-22d0-4adb9883d309" xlink:to="loc_us-gaap_DerivativeLiabilitiesCurrent_c2051fc9-6e3c-3055-fde4-401ea0dbd57b" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingencyAccrualCarryingValueCurrent" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValueCurrent_54c7bb77-c2eb-328b-6ad7-404e3c0b87cb" xlink:type="locator" />
    <link:calculationArc order="13" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_c90cf113-b51b-4312-22d0-4adb9883d309" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValueCurrent_54c7bb77-c2eb-328b-6ad7-404e3c0b87cb" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_fa7787c9-a33c-d084-bb97-5e2455f77a4c" xlink:type="locator" />
    <link:calculationArc order="14" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_c90cf113-b51b-4312-22d0-4adb9883d309" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_fa7787c9-a33c-d084-bb97-5e2455f77a4c" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/CertainBalanceSheetItemsPropertyAndEquipmentDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_4246ec24-1a4c-19dd-57c9-32d4a8e0cbaa" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_94cd7971-9d17-1c6e-6642-d4d38fb682b6" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_4246ec24-1a4c-19dd-57c9-32d4a8e0cbaa" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_94cd7971-9d17-1c6e-6642-d4d38fb682b6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_7b7a3a8d-eb3d-0c85-68cc-b3d4d184ff23" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_4246ec24-1a4c-19dd-57c9-32d4a8e0cbaa" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_7b7a3a8d-eb3d-0c85-68cc-b3d4d184ff23" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/CertainBalanceSheetItemsTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/CollaborationAndLicenseAgreementAndAssetAcquisition" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/CollaborationAndLicenseAgreementAndAssetAcquisitionNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/CollaborationAndLicenseAgreementAndAssetAcquisitionScheduleOfAssetAcquisitionDetails" xlink:type="extended">
    <link:loc xlink:href="jazz-20190930.xsd#jazz_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="loc_jazz_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_12A0A2F957800C58003F237D226403C0" xlink:type="locator" />
    <link:loc xlink:href="jazz-20190930.xsd#jazz_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_jazz_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_22244E9310EE68E5003EF08A0B781447" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_jazz_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_12A0A2F957800C58003F237D226403C0" xlink:to="loc_jazz_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_22244E9310EE68E5003EF08A0B781447" xlink:type="arc" />
    <link:loc xlink:href="jazz-20190930.xsd#jazz_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:label="loc_jazz_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_501BBDACCDD87AB40B52F0904488DF04" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_jazz_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_12A0A2F957800C58003F237D226403C0" xlink:to="loc_jazz_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_501BBDACCDD87AB40B52F0904488DF04" xlink:type="arc" />
    <link:loc xlink:href="jazz-20190930.xsd#jazz_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:label="loc_jazz_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_A8AA37A96C606218D484F0915596DFAE" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_jazz_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_12A0A2F957800C58003F237D226403C0" xlink:to="loc_jazz_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_A8AA37A96C606218D484F0915596DFAE" xlink:type="arc" />
    <link:loc xlink:href="jazz-20190930.xsd#jazz_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssetsAndLiabilitiesNet" xlink:label="loc_jazz_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssetsAndLiabilitiesNet_5ACF0911CB575308C178F092F3949F34" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_jazz_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_12A0A2F957800C58003F237D226403C0" xlink:to="loc_jazz_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssetsAndLiabilitiesNet_5ACF0911CB575308C178F092F3949F34" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/CollaborationAndLicenseAgreementAndAssetAcquisitionTablesTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/CommitmentsAndContingencies" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/CommitmentsAndContingenciesNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/CompanyAndSummaryOfSignificantAccountingPolicies" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/CompanyAndSummaryOfSignificantAccountingPoliciesAdoptionOfNewAccountingStandardsNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/CompanyAndSummaryOfSignificantAccountingPoliciesBasisOfPresentationNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/CompanyAndSummaryOfSignificantAccountingPoliciesConcentrationsOfRiskNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/CompanyAndSummaryOfSignificantAccountingPoliciesCumulativeEffectOnConsolidatedBalanceSheetDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/CompanyAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/CompanyAndSummaryOfSignificantAccountingPoliciesTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_6437DF98B0385B6E8500DC14A8374BDB" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_2A0FB3D2BB71567BBFF611ED58A796A3" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6437DF98B0385B6E8500DC14A8374BDB" xlink:to="loc_us-gaap_AssetsCurrent_2A0FB3D2BB71567BBFF611ED58A796A3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8AC35AD9717C532680FCB1F7DBD1274A" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_2A0FB3D2BB71567BBFF611ED58A796A3" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8AC35AD9717C532680FCB1F7DBD1274A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Investments" xlink:label="loc_us-gaap_Investments_2D14296723465CE8A68E33EFD2C28059" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_2A0FB3D2BB71567BBFF611ED58A796A3" xlink:to="loc_us-gaap_Investments_2D14296723465CE8A68E33EFD2C28059" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_BF438E20813D530D88D41559B3A62A7E" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_2A0FB3D2BB71567BBFF611ED58A796A3" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_BF438E20813D530D88D41559B3A62A7E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_0C56D5F2F3695309AACD12CC1DC351D5" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_2A0FB3D2BB71567BBFF611ED58A796A3" xlink:to="loc_us-gaap_InventoryNet_0C56D5F2F3695309AACD12CC1DC351D5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_C5B3A8A761A05B1599C6BF6FA4DAF5DA" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_2A0FB3D2BB71567BBFF611ED58A796A3" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_C5B3A8A761A05B1599C6BF6FA4DAF5DA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaap_OtherAssetsCurrent_BDBB1916CFBD5DF481FE9445B95BE1F7" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_2A0FB3D2BB71567BBFF611ED58A796A3" xlink:to="loc_us-gaap_OtherAssetsCurrent_BDBB1916CFBD5DF481FE9445B95BE1F7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_4992649A38655F5E87779BD54530A4C2" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6437DF98B0385B6E8500DC14A8374BDB" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_4992649A38655F5E87779BD54530A4C2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_ECC79CF015D0512C857D896A8633AA83" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6437DF98B0385B6E8500DC14A8374BDB" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_ECC79CF015D0512C857D896A8633AA83" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_15F93D5ABEB152AA8E00334873E46DB2" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6437DF98B0385B6E8500DC14A8374BDB" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_15F93D5ABEB152AA8E00334873E46DB2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_E947EC2CCFE151D1ACC89D0200E8D56B" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6437DF98B0385B6E8500DC14A8374BDB" xlink:to="loc_us-gaap_Goodwill_E947EC2CCFE151D1ACC89D0200E8D56B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_EF0FA668EE005F1EA05898D27A9763CB" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6437DF98B0385B6E8500DC14A8374BDB" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_EF0FA668EE005F1EA05898D27A9763CB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:label="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_3E7645C925D0520EA52FAF67653CFB65" xlink:type="locator" />
    <link:calculationArc order="7" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6437DF98B0385B6E8500DC14A8374BDB" xlink:to="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_3E7645C925D0520EA52FAF67653CFB65" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_65B36622CEE15E6D878AA14F0725D9F3" xlink:type="locator" />
    <link:calculationArc order="8" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6437DF98B0385B6E8500DC14A8374BDB" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_65B36622CEE15E6D878AA14F0725D9F3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_8F3E767DEF485A2B93F150CC716701FB" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_361FCA1AEF105D25BAD8EF6D66E95D82" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_8F3E767DEF485A2B93F150CC716701FB" xlink:to="loc_us-gaap_LiabilitiesCurrent_361FCA1AEF105D25BAD8EF6D66E95D82" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_A54189C16A1D5995A8C635C0A1F647C9" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_361FCA1AEF105D25BAD8EF6D66E95D82" xlink:to="loc_us-gaap_AccountsPayableCurrent_A54189C16A1D5995A8C635C0A1F647C9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_490B321DAE2C528990F92A5D90794C6B" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_361FCA1AEF105D25BAD8EF6D66E95D82" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_490B321DAE2C528990F92A5D90794C6B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaap_LongTermDebtCurrent_75DEEB030197554DA3468CED4F632966" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_361FCA1AEF105D25BAD8EF6D66E95D82" xlink:to="loc_us-gaap_LongTermDebtCurrent_75DEEB030197554DA3468CED4F632966" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TaxesPayableCurrent" xlink:label="loc_us-gaap_TaxesPayableCurrent_BFDE56E8B8885F789EE053E14430568C" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_361FCA1AEF105D25BAD8EF6D66E95D82" xlink:to="loc_us-gaap_TaxesPayableCurrent_BFDE56E8B8885F789EE053E14430568C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_64BCBA764D325F8682975E323BAFCF87" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_361FCA1AEF105D25BAD8EF6D66E95D82" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_64BCBA764D325F8682975E323BAFCF87" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_D6941C0981AB5CC195423C136827D55D" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_8F3E767DEF485A2B93F150CC716701FB" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_D6941C0981AB5CC195423C136827D55D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_490839CE030E5DB38239852BDAAF6E6B" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_8F3E767DEF485A2B93F150CC716701FB" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_490839CE030E5DB38239852BDAAF6E6B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_815EB2430A91582AADDDA572A1ED2783" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_8F3E767DEF485A2B93F150CC716701FB" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_815EB2430A91582AADDDA572A1ED2783" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_26F5A8456DA858F48CD4DBA30019EBDB" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_8F3E767DEF485A2B93F150CC716701FB" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_26F5A8456DA858F48CD4DBA30019EBDB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_B3C3CDDD0A05542CBABFAD5774A9B6CF" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_8F3E767DEF485A2B93F150CC716701FB" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_B3C3CDDD0A05542CBABFAD5774A9B6CF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies_5F1AF6DF1E1D554FA0524EE00924073F" xlink:type="locator" />
    <link:calculationArc order="7" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_8F3E767DEF485A2B93F150CC716701FB" xlink:to="loc_us-gaap_CommitmentsAndContingencies_5F1AF6DF1E1D554FA0524EE00924073F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_F33ECF956A615A81AA3E6B6330C7BA21" xlink:type="locator" />
    <link:calculationArc order="8" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_8F3E767DEF485A2B93F150CC716701FB" xlink:to="loc_us-gaap_StockholdersEquity_F33ECF956A615A81AA3E6B6330C7BA21" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_BF9EC72C4FED5827856152A8D64CA410" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_F33ECF956A615A81AA3E6B6330C7BA21" xlink:to="loc_us-gaap_CommonStockValue_BF9EC72C4FED5827856152A8D64CA410" xlink:type="arc" />
    <link:loc xlink:href="jazz-20190930.xsd#jazz_NonvotingEuroDeferredShares" xlink:label="loc_jazz_NonvotingEuroDeferredShares_C0B4362269935A10AB8B519FED58ECC0" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_F33ECF956A615A81AA3E6B6330C7BA21" xlink:to="loc_jazz_NonvotingEuroDeferredShares_C0B4362269935A10AB8B519FED58ECC0" xlink:type="arc" />
    <link:loc xlink:href="jazz-20190930.xsd#jazz_CapitalRedemptionReserve" xlink:label="loc_jazz_CapitalRedemptionReserve_879F672DCD6A5E08B7BA4AEFDD8F43FC" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_F33ECF956A615A81AA3E6B6330C7BA21" xlink:to="loc_jazz_CapitalRedemptionReserve_879F672DCD6A5E08B7BA4AEFDD8F43FC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_F14B56C25B17510B82DD91BC07B872AF" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_F33ECF956A615A81AA3E6B6330C7BA21" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_F14B56C25B17510B82DD91BC07B872AF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_A82E854BCA06568C9152D0EC3198CBBB" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_F33ECF956A615A81AA3E6B6330C7BA21" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_A82E854BCA06568C9152D0EC3198CBBB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_D9A7997FEC7655BC914434022531997A" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_F33ECF956A615A81AA3E6B6330C7BA21" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_D9A7997FEC7655BC914434022531997A" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/CondensedConsolidatedStatementsOfCashFlows" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_50231013-f048-89e7-0e20-ba139224c5f7" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ce0d7b63-a366-bc9b-79e1-780981e428fe" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_50231013-f048-89e7-0e20-ba139224c5f7" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ce0d7b63-a366-bc9b-79e1-780981e428fe" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_e170ce1e-c3a8-e8ee-88b0-37e8dd7b1d11" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ce0d7b63-a366-bc9b-79e1-780981e428fe" xlink:to="loc_us-gaap_NetIncomeLoss_e170ce1e-c3a8-e8ee-88b0-37e8dd7b1d11" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_725ae160-1b15-a075-fa62-729d0bc8cda1" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ce0d7b63-a366-bc9b-79e1-780981e428fe" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_725ae160-1b15-a075-fa62-729d0bc8cda1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_f0b9d825-b0b9-37fd-4d25-9294a8598890" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ce0d7b63-a366-bc9b-79e1-780981e428fe" xlink:to="loc_us-gaap_ShareBasedCompensation_f0b9d825-b0b9-37fd-4d25-9294a8598890" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetImpairmentCharges" xlink:label="loc_us-gaap_AssetImpairmentCharges_b5495221-c933-5c88-514e-d2731414949c" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ce0d7b63-a366-bc9b-79e1-780981e428fe" xlink:to="loc_us-gaap_AssetImpairmentCharges_b5495221-c933-5c88-514e-d2731414949c" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaap_Depreciation_848cd271-4e03-8c13-d21d-e6ec9c3916f7" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ce0d7b63-a366-bc9b-79e1-780981e428fe" xlink:to="loc_us-gaap_Depreciation_848cd271-4e03-8c13-d21d-e6ec9c3916f7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff" xlink:label="loc_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_472cc873-2199-d80f-236e-5c4810356974" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ce0d7b63-a366-bc9b-79e1-780981e428fe" xlink:to="loc_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_472cc873-2199-d80f-236e-5c4810356974" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets1" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets1_73cabc52-c416-1a4a-0557-7c2672849759" xlink:type="locator" />
    <link:calculationArc order="7" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ce0d7b63-a366-bc9b-79e1-780981e428fe" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets1_73cabc52-c416-1a4a-0557-7c2672849759" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_3421bed6-296e-da4e-f0e9-a2a8fa1f6d19" xlink:type="locator" />
    <link:calculationArc order="8" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ce0d7b63-a366-bc9b-79e1-780981e428fe" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_3421bed6-296e-da4e-f0e9-a2a8fa1f6d19" xlink:type="arc" />
    <link:loc xlink:href="jazz-20190930.xsd#jazz_ProvisionForLossesOnAccountsReceivableAndInventory" xlink:label="loc_jazz_ProvisionForLossesOnAccountsReceivableAndInventory_4abe3c29-3885-830d-78dc-05d64f30d2c7" xlink:type="locator" />
    <link:calculationArc order="9" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ce0d7b63-a366-bc9b-79e1-780981e428fe" xlink:to="loc_jazz_ProvisionForLossesOnAccountsReceivableAndInventory_4abe3c29-3885-830d-78dc-05d64f30d2c7" xlink:type="arc" />
    <link:loc xlink:href="jazz-20190930.xsd#jazz_GainLossonExtinguishmentandModificationofDebt" xlink:label="loc_jazz_GainLossonExtinguishmentandModificationofDebt_e1dee99d-fdbc-2add-1eba-05d64c57b6c4" xlink:type="locator" />
    <link:calculationArc order="10" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ce0d7b63-a366-bc9b-79e1-780981e428fe" xlink:to="loc_jazz_GainLossonExtinguishmentandModificationofDebt_e1dee99d-fdbc-2add-1eba-05d64c57b6c4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_c839a0d8-dfea-e1a5-fc91-ef95e7aed9cb" xlink:type="locator" />
    <link:calculationArc order="11" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ce0d7b63-a366-bc9b-79e1-780981e428fe" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_c839a0d8-dfea-e1a5-fc91-ef95e7aed9cb" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_269710de-43ea-f1a2-1ab7-8a2fad8bcd72" xlink:type="locator" />
    <link:calculationArc order="12" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ce0d7b63-a366-bc9b-79e1-780981e428fe" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_269710de-43ea-f1a2-1ab7-8a2fad8bcd72" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_09b7b41a-f5a1-c45e-d61b-846fff462802" xlink:type="locator" />
    <link:calculationArc order="13" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ce0d7b63-a366-bc9b-79e1-780981e428fe" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_09b7b41a-f5a1-c45e-d61b-846fff462802" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_f2b34f8d-2445-12ee-2c68-fa0c5409d5e0" xlink:type="locator" />
    <link:calculationArc order="14" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ce0d7b63-a366-bc9b-79e1-780981e428fe" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_f2b34f8d-2445-12ee-2c68-fa0c5409d5e0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_dfcbd6f7-83fa-00c2-bd9e-6c5c1de7d890" xlink:type="locator" />
    <link:calculationArc order="15" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ce0d7b63-a366-bc9b-79e1-780981e428fe" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_dfcbd6f7-83fa-00c2-bd9e-6c5c1de7d890" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_596f4189-155d-4012-cbaf-764843162122" xlink:type="locator" />
    <link:calculationArc order="16" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ce0d7b63-a366-bc9b-79e1-780981e428fe" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_596f4189-155d-4012-cbaf-764843162122" xlink:type="arc" />
    <link:loc xlink:href="jazz-20190930.xsd#jazz_IncreaseDecreaseInOperatingLeaseAssets" xlink:label="loc_jazz_IncreaseDecreaseInOperatingLeaseAssets_C3CACC0DAB19792CD253060FC8E9A3D8" xlink:type="locator" />
    <link:calculationArc order="17" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ce0d7b63-a366-bc9b-79e1-780981e428fe" xlink:to="loc_jazz_IncreaseDecreaseInOperatingLeaseAssets_C3CACC0DAB19792CD253060FC8E9A3D8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_792166b2-b561-55ef-12fd-ca8b50f64a38" xlink:type="locator" />
    <link:calculationArc order="18" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ce0d7b63-a366-bc9b-79e1-780981e428fe" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_792166b2-b561-55ef-12fd-ca8b50f64a38" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_c8705fc2-a98a-ac1d-2832-812bd5cae0da" xlink:type="locator" />
    <link:calculationArc order="19" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ce0d7b63-a366-bc9b-79e1-780981e428fe" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_c8705fc2-a98a-ac1d-2832-812bd5cae0da" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_6933b079-472c-4409-d821-646ed2de772d" xlink:type="locator" />
    <link:calculationArc order="20" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ce0d7b63-a366-bc9b-79e1-780981e428fe" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_6933b079-472c-4409-d821-646ed2de772d" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_8fa19589-0da6-036d-a79e-4bd2fa365a6d" xlink:type="locator" />
    <link:calculationArc order="21" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ce0d7b63-a366-bc9b-79e1-780981e428fe" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_8fa19589-0da6-036d-a79e-4bd2fa365a6d" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_2aae5a95-d2bb-f83c-eefc-57ef1463b480" xlink:type="locator" />
    <link:calculationArc order="22" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ce0d7b63-a366-bc9b-79e1-780981e428fe" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_2aae5a95-d2bb-f83c-eefc-57ef1463b480" xlink:type="arc" />
    <link:loc xlink:href="jazz-20190930.xsd#jazz_IncreaseDecreaseInOperatingLeaseLiabilitiesNoncurrent" xlink:label="loc_jazz_IncreaseDecreaseInOperatingLeaseLiabilitiesNoncurrent_260F5A12E62A636379280611A0BF938F" xlink:type="locator" />
    <link:calculationArc order="23" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ce0d7b63-a366-bc9b-79e1-780981e428fe" xlink:to="loc_jazz_IncreaseDecreaseInOperatingLeaseLiabilitiesNoncurrent_260F5A12E62A636379280611A0BF938F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0f07a806-a2da-6d18-a7a9-d734fad1f3b0" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_50231013-f048-89e7-0e20-ba139224c5f7" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0f07a806-a2da-6d18-a7a9-d734fad1f3b0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:label="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_93f5c047-4b64-266d-dad0-d21441a97f7a" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0f07a806-a2da-6d18-a7a9-d734fad1f3b0" xlink:to="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_93f5c047-4b64-266d-dad0-d21441a97f7a" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:label="loc_us-gaap_ProceedsFromSaleOfProductiveAssets_578f24f8-46e7-25b5-2c9d-a8a5bbd8f335" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0f07a806-a2da-6d18-a7a9-d734fad1f3b0" xlink:to="loc_us-gaap_ProceedsFromSaleOfProductiveAssets_578f24f8-46e7-25b5-2c9d-a8a5bbd8f335" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_a73d82d7-3d54-5ea8-2d2f-c40454b71639" xlink:type="locator" />
    <link:calculationArc order="3" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0f07a806-a2da-6d18-a7a9-d734fad1f3b0" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssets_a73d82d7-3d54-5ea8-2d2f-c40454b71639" xlink:type="arc" />
    <link:loc xlink:href="jazz-20190930.xsd#jazz_PaymentToAcquireAssetsNetOfCashAcquired" xlink:label="loc_jazz_PaymentToAcquireAssetsNetOfCashAcquired_C90DF128C555001B6438F0A5AEE595C5" xlink:type="locator" />
    <link:calculationArc order="4" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0f07a806-a2da-6d18-a7a9-d734fad1f3b0" xlink:to="loc_jazz_PaymentToAcquireAssetsNetOfCashAcquired_C90DF128C555001B6438F0A5AEE595C5" xlink:type="arc" />
    <link:loc xlink:href="jazz-20190930.xsd#jazz_PaymentstoAcquireInProcessResearchandDevelopmentOtherThanThroughBusinessCombination" xlink:label="loc_jazz_PaymentstoAcquireInProcessResearchandDevelopmentOtherThanThroughBusinessCombination_53d7562a-0cbd-3224-580a-05d64da71779" xlink:type="locator" />
    <link:calculationArc order="5" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0f07a806-a2da-6d18-a7a9-d734fad1f3b0" xlink:to="loc_jazz_PaymentstoAcquireInProcessResearchandDevelopmentOtherThanThroughBusinessCombination_53d7562a-0cbd-3224-580a-05d64da71779" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_fabd36b2-0d2f-8f1e-b9c9-718513456b78" xlink:type="locator" />
    <link:calculationArc order="6" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0f07a806-a2da-6d18-a7a9-d734fad1f3b0" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_fabd36b2-0d2f-8f1e-b9c9-718513456b78" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireInvestments" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_d3769ff7-3f7d-8a64-ea69-f16e64d6f178" xlink:type="locator" />
    <link:calculationArc order="7" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0f07a806-a2da-6d18-a7a9-d734fad1f3b0" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_d3769ff7-3f7d-8a64-ea69-f16e64d6f178" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1efd93c0-bb90-2a64-a997-3a70afaa3faa" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_50231013-f048-89e7-0e20-ba139224c5f7" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1efd93c0-bb90-2a64-a997-3a70afaa3faa" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_3b304564-1a0d-03c8-a331-770e72d1f6fc" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1efd93c0-bb90-2a64-a997-3a70afaa3faa" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_3b304564-1a0d-03c8-a331-770e72d1f6fc" xlink:type="arc" />
    <link:loc xlink:href="jazz-20190930.xsd#jazz_PaymentsForProceedsFromTenantAllowanceFinancingActivities" xlink:label="loc_jazz_PaymentsForProceedsFromTenantAllowanceFinancingActivities_31d969e1-dce3-7094-0784-05d64eeb6945" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1efd93c0-bb90-2a64-a997-3a70afaa3faa" xlink:to="loc_jazz_PaymentsForProceedsFromTenantAllowanceFinancingActivities_31d969e1-dce3-7094-0784-05d64eeb6945" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsOfDebtRestructuringCosts" xlink:label="loc_us-gaap_PaymentsOfDebtRestructuringCosts_f3ad89c2-1775-39ac-fe95-fbc43a216dea" xlink:type="locator" />
    <link:calculationArc order="3" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1efd93c0-bb90-2a64-a997-3a70afaa3faa" xlink:to="loc_us-gaap_PaymentsOfDebtRestructuringCosts_f3ad89c2-1775-39ac-fe95-fbc43a216dea" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_07e50027-f2db-6d1b-93ed-b22d6bd39351" xlink:type="locator" />
    <link:calculationArc order="4" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1efd93c0-bb90-2a64-a997-3a70afaa3faa" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_07e50027-f2db-6d1b-93ed-b22d6bd39351" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfSecuredDebt" xlink:label="loc_us-gaap_RepaymentsOfSecuredDebt_af7d3505-6faf-ba7f-4018-9f6bdebb883a" xlink:type="locator" />
    <link:calculationArc order="5" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1efd93c0-bb90-2a64-a997-3a70afaa3faa" xlink:to="loc_us-gaap_RepaymentsOfSecuredDebt_af7d3505-6faf-ba7f-4018-9f6bdebb883a" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_3f804297-91a1-3939-541d-a39b6288c9f9" xlink:type="locator" />
    <link:calculationArc order="6" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1efd93c0-bb90-2a64-a997-3a70afaa3faa" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_3f804297-91a1-3939-541d-a39b6288c9f9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6bd7c3da-2a5b-cbc6-d33a-bb097a23c2f6" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_50231013-f048-89e7-0e20-ba139224c5f7" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6bd7c3da-2a5b-cbc6-d33a-bb097a23c2f6" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_5c8b3520-1ca2-0a91-0912-70d62831826c" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_e170ce1e-c3a8-e8ee-88b0-37e8dd7b1d11" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_5c8b3520-1ca2-0a91-0912-70d62831826c" xlink:to="loc_us-gaap_NetIncomeLoss_e170ce1e-c3a8-e8ee-88b0-37e8dd7b1d11" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_5e0cb0dc-b25c-aaae-62f8-cb90f31a16a1" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_5c8b3520-1ca2-0a91-0912-70d62831826c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_5e0cb0dc-b25c-aaae-62f8-cb90f31a16a1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_68a2669c-01f8-c962-bf95-0b4231cd45da" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_5e0cb0dc-b25c-aaae-62f8-cb90f31a16a1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_68a2669c-01f8-c962-bf95-0b4231cd45da" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_5d6a244f-545f-188e-391b-fc8aa0768131" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_5e0cb0dc-b25c-aaae-62f8-cb90f31a16a1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_5d6a244f-545f-188e-391b-fc8aa0768131" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeParenthetical" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/CondensedConsolidatedStatementsOfIncome" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_62AA72B31E1A5B539550FEC596AF67B5" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_60DA6D08AEA451D6947F5515906CBF7D" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_62AA72B31E1A5B539550FEC596AF67B5" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_60DA6D08AEA451D6947F5515906CBF7D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_3970455837A5547A822B5BFC8C858544" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_60DA6D08AEA451D6947F5515906CBF7D" xlink:to="loc_us-gaap_OperatingIncomeLoss_3970455837A5547A822B5BFC8C858544" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2C5CB34139915458BB11603D0EB8FFD1" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_3970455837A5547A822B5BFC8C858544" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2C5CB34139915458BB11603D0EB8FFD1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostsAndExpenses" xlink:label="loc_us-gaap_CostsAndExpenses_6B783E2E710E5B579926601292543814" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_3970455837A5547A822B5BFC8C858544" xlink:to="loc_us-gaap_CostsAndExpenses_6B783E2E710E5B579926601292543814" xlink:type="arc" />
    <link:loc xlink:href="jazz-20190930.xsd#jazz_CostOfProductSalesExcludingAmortizationOfAcquiredDevelopedTechnologyAndIntangibleAssetImpairment" xlink:label="loc_jazz_CostOfProductSalesExcludingAmortizationOfAcquiredDevelopedTechnologyAndIntangibleAssetImpairment_66A7BAD619FD5BECA1E4960825275377" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_6B783E2E710E5B579926601292543814" xlink:to="loc_jazz_CostOfProductSalesExcludingAmortizationOfAcquiredDevelopedTechnologyAndIntangibleAssetImpairment_66A7BAD619FD5BECA1E4960825275377" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_C3FB02961FC65545864346E76874D219" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_6B783E2E710E5B579926601292543814" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_C3FB02961FC65545864346E76874D219" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_BB1F5021377958458F68114F2B7E55B0" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_6B783E2E710E5B579926601292543814" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_BB1F5021377958458F68114F2B7E55B0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_19414FF194EF5605889D701CFC8896A9" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_6B783E2E710E5B579926601292543814" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_19414FF194EF5605889D701CFC8896A9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetImpairmentCharges" xlink:label="loc_us-gaap_AssetImpairmentCharges_B517A16DA1E650AE8D052B06E9F5EFBF" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_6B783E2E710E5B579926601292543814" xlink:to="loc_us-gaap_AssetImpairmentCharges_B517A16DA1E650AE8D052B06E9F5EFBF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff" xlink:label="loc_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_5E2FE66F24675B4598DE512F48496FAA" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_6B783E2E710E5B579926601292543814" xlink:to="loc_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_5E2FE66F24675B4598DE512F48496FAA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_06D0B198ECB55698AEBA9B05864C8D24" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_60DA6D08AEA451D6947F5515906CBF7D" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_06D0B198ECB55698AEBA9B05864C8D24" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_4E3100C17DB65949BD46B8B83CA4CC30" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_60DA6D08AEA451D6947F5515906CBF7D" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_4E3100C17DB65949BD46B8B83CA4CC30" xlink:type="arc" />
    <link:loc xlink:href="jazz-20190930.xsd#jazz_GainLossonExtinguishmentandModificationofDebt" xlink:label="loc_jazz_GainLossonExtinguishmentandModificationofDebt_CCA5074B63DF58B9936230805F9B717D" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_60DA6D08AEA451D6947F5515906CBF7D" xlink:to="loc_jazz_GainLossonExtinguishmentandModificationofDebt_CCA5074B63DF58B9936230805F9B717D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_25E4FF4DBF5151359AB3F98BB8B037D5" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_62AA72B31E1A5B539550FEC596AF67B5" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_25E4FF4DBF5151359AB3F98BB8B037D5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_FA87F48B10D35D15A78E111FB9ECC311" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_62AA72B31E1A5B539550FEC596AF67B5" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_FA87F48B10D35D15A78E111FB9ECC311" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/CondensedConsolidatedStatementsOfShareholdersEquity" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/Cover" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/Debt" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/DebtNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/DebtScheduleOfLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaap_LongTermDebt_AA75F365C5F15EE593512992256F3066" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaap_LongTermDebtCurrent_75DEEB030197554DA3468CED4F632966" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_AA75F365C5F15EE593512992256F3066" xlink:to="loc_us-gaap_LongTermDebtCurrent_75DEEB030197554DA3468CED4F632966" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_490839CE030E5DB38239852BDAAF6E6B" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_AA75F365C5F15EE593512992256F3066" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_490839CE030E5DB38239852BDAAF6E6B" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/DebtScheduleOfLongTermDebtDetailsCalc2" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaap_LongTermDebt_555EF58C73185F1DFBEA6749D000A780_AA75F365C5F15EE593512992256F3066" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_555EF58C73185F1DFBEA6749D000A780_B9B8751CACEE55668C7CF292A13CB921" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_555EF58C73185F1DFBEA6749D000A780_AA75F365C5F15EE593512992256F3066" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_555EF58C73185F1DFBEA6749D000A780_B9B8751CACEE55668C7CF292A13CB921" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_555EF58C73185F1DFBEA6749D000A780_20AA6042C3AF55E490E9AED9048CB959" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_555EF58C73185F1DFBEA6749D000A780_AA75F365C5F15EE593512992256F3066" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_555EF58C73185F1DFBEA6749D000A780_20AA6042C3AF55E490E9AED9048CB959" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/DebtScheduleOfMaturitiesOfLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_b5390da0-4b10-f083-5d88-d4657fa5b028" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_5a8b47c3-ce9e-0992-6c29-f7284d4ea136" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_b5390da0-4b10-f083-5d88-d4657fa5b028" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_5a8b47c3-ce9e-0992-6c29-f7284d4ea136" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_ce3ac95b-761b-7fbc-3779-1bdfd056c71f" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_b5390da0-4b10-f083-5d88-d4657fa5b028" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_ce3ac95b-761b-7fbc-3779-1bdfd056c71f" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_d39bb101-f79f-a162-9929-01083e9d64b5" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_b5390da0-4b10-f083-5d88-d4657fa5b028" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_d39bb101-f79f-a162-9929-01083e9d64b5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_73238937-86a2-9126-69f0-c70629155ebe" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_b5390da0-4b10-f083-5d88-d4657fa5b028" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_73238937-86a2-9126-69f0-c70629155ebe" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_a170264f-50ba-a4bb-6d22-ec86b5249633" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_b5390da0-4b10-f083-5d88-d4657fa5b028" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_a170264f-50ba-a4bb-6d22-ec86b5249633" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_da82f4c2-6e6f-ccde-a6bf-f559322a3267" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_b5390da0-4b10-f083-5d88-d4657fa5b028" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_da82f4c2-6e6f-ccde-a6bf-f559322a3267" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/DebtTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/DerivativeInstrumentsAndHedgingActivities" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/DerivativeInstrumentsAndHedgingActivitiesFairValueOfOutstandingDerivativesDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/DerivativeInstrumentsAndHedgingActivitiesForeignExchangeGainLossDerivativeInstrumentsDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/DerivativeInstrumentsAndHedgingActivitiesGainsOnDerivativeInstrumentsDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/DerivativeInstrumentsAndHedgingActivitiesNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/DerivativeInstrumentsAndHedgingActivitiesOffsettingAssetsAndLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral_69913E66C96F53808A9E3DEBC34C260F" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeAssets" xlink:label="loc_us-gaap_DerivativeAssets_4C070F485F845C2C88BD411B3638277D" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral_69913E66C96F53808A9E3DEBC34C260F" xlink:to="loc_us-gaap_DerivativeAssets_4C070F485F845C2C88BD411B3638277D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_1A3CEB150E24537599CE6D9C40DC2B98" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeAssets_4C070F485F845C2C88BD411B3638277D" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_1A3CEB150E24537599CE6D9C40DC2B98" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeAssetFairValueGrossLiability" xlink:label="loc_us-gaap_DerivativeAssetFairValueGrossLiability_7C077689954D5370BCB3A9E9985CA063" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeAssets_4C070F485F845C2C88BD411B3638277D" xlink:to="loc_us-gaap_DerivativeAssetFairValueGrossLiability_7C077689954D5370BCB3A9E9985CA063" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeCollateralObligationToReturnSecurities" xlink:label="loc_us-gaap_DerivativeCollateralObligationToReturnSecurities_3A1CC5E429285035897EC772A5DCC229" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral_69913E66C96F53808A9E3DEBC34C260F" xlink:to="loc_us-gaap_DerivativeCollateralObligationToReturnSecurities_3A1CC5E429285035897EC772A5DCC229" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeCollateralObligationToReturnCash" xlink:label="loc_us-gaap_DerivativeCollateralObligationToReturnCash_C9B047295E3C509EB93906A4E0C4754B" xlink:type="locator" />
    <link:calculationArc order="3" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral_69913E66C96F53808A9E3DEBC34C260F" xlink:to="loc_us-gaap_DerivativeCollateralObligationToReturnCash_C9B047295E3C509EB93906A4E0C4754B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral_81C2D04F682957B6A4D63D07F0B9708C" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLiabilities" xlink:label="loc_us-gaap_DerivativeLiabilities_B2B0217107D952949E554E4716D50CC2" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral_81C2D04F682957B6A4D63D07F0B9708C" xlink:to="loc_us-gaap_DerivativeLiabilities_B2B0217107D952949E554E4716D50CC2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_7717F956A47350EBBF88F7FBE0EB119F" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeLiabilities_B2B0217107D952949E554E4716D50CC2" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_7717F956A47350EBBF88F7FBE0EB119F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLiabilityFairValueGrossAsset" xlink:label="loc_us-gaap_DerivativeLiabilityFairValueGrossAsset_65DDC10D52A05D35A88FDA879F47319C" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeLiabilities_B2B0217107D952949E554E4716D50CC2" xlink:to="loc_us-gaap_DerivativeLiabilityFairValueGrossAsset_65DDC10D52A05D35A88FDA879F47319C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeCollateralRightToReclaimSecurities" xlink:label="loc_us-gaap_DerivativeCollateralRightToReclaimSecurities_FCDEDFAF0F0458F49E2D3CB83931B2B1" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral_81C2D04F682957B6A4D63D07F0B9708C" xlink:to="loc_us-gaap_DerivativeCollateralRightToReclaimSecurities_FCDEDFAF0F0458F49E2D3CB83931B2B1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeCollateralRightToReclaimCash" xlink:label="loc_us-gaap_DerivativeCollateralRightToReclaimCash_1C0BAC45464551F585D6BE663654B6D4" xlink:type="locator" />
    <link:calculationArc order="3" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral_81C2D04F682957B6A4D63D07F0B9708C" xlink:to="loc_us-gaap_DerivativeCollateralRightToReclaimCash_1C0BAC45464551F585D6BE663654B6D4" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/DerivativeInstrumentsAndHedgingActivitiesTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/FairValueMeasurement" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/FairValueMeasurementAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_FD55556767BB5272AA484DEDF22910C9" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_816C02FC49C65CD59735FA63A3B513DB" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_FD55556767BB5272AA484DEDF22910C9" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_816C02FC49C65CD59735FA63A3B513DB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeAssets" xlink:label="loc_us-gaap_DerivativeAssets_4C070F485F845C2C88BD411B3638277D" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_FD55556767BB5272AA484DEDF22910C9" xlink:to="loc_us-gaap_DerivativeAssets_4C070F485F845C2C88BD411B3638277D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_F05CA87BF55156F5888D97B74F3BFFC0" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLiabilities" xlink:label="loc_us-gaap_DerivativeLiabilities_B2B0217107D952949E554E4716D50CC2" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_F05CA87BF55156F5888D97B74F3BFFC0" xlink:to="loc_us-gaap_DerivativeLiabilities_B2B0217107D952949E554E4716D50CC2" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/FairValueMeasurementNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/FairValueMeasurementTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/GoodwillAndIntangibleAssets" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/GoodwillAndIntangibleAssetsEstimatedFutureAmortizationCostsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_e87bd6a3-2026-a858-f41a-bc281e5d594b" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_161efa93-4fc3-b3e6-9a97-d8d9aeebe0cc" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_e87bd6a3-2026-a858-f41a-bc281e5d594b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_161efa93-4fc3-b3e6-9a97-d8d9aeebe0cc" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_52d5fc42-d7bd-e657-728c-68a54a8a27d9" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_e87bd6a3-2026-a858-f41a-bc281e5d594b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_52d5fc42-d7bd-e657-728c-68a54a8a27d9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_28209536-91f9-47af-f5bd-6accbeed43b7" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_e87bd6a3-2026-a858-f41a-bc281e5d594b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_28209536-91f9-47af-f5bd-6accbeed43b7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_716ff456-95a9-c7d8-efd5-2047c2ac3646" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_e87bd6a3-2026-a858-f41a-bc281e5d594b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_716ff456-95a9-c7d8-efd5-2047c2ac3646" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_db859267-14f1-73e3-47c3-03bfc9627628" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_e87bd6a3-2026-a858-f41a-bc281e5d594b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_db859267-14f1-73e3-47c3-03bfc9627628" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_fa802f8f-3c6f-18ed-005d-e578d38097d8" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_e87bd6a3-2026-a858-f41a-bc281e5d594b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_fa802f8f-3c6f-18ed-005d-e578d38097d8" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/GoodwillAndIntangibleAssetsGoodwillActivityDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/GoodwillAndIntangibleAssetsGrossCarryingAmountsAndNetBookValuesOfIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_CD6B3C018859516BABA348A9D73D6A06" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_CF2F3A7E7BCA564B8BC556D6865C25BE" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_CD6B3C018859516BABA348A9D73D6A06" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_CF2F3A7E7BCA564B8BC556D6865C25BE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_BF26246EF94D5B549B1351C1BB502D74" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_CD6B3C018859516BABA348A9D73D6A06" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_BF26246EF94D5B549B1351C1BB502D74" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_15F93D5ABEB152AA8E00334873E46DB2" xlink:type="locator" />
    <link:calculationArc order="1" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_15F93D5ABEB152AA8E00334873E46DB2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_BF26246EF94D5B549B1351C1BB502D74" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_A25BFCA1E3BD5D3B9E1D4981F1A51A83" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_15F93D5ABEB152AA8E00334873E46DB2" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_A25BFCA1E3BD5D3B9E1D4981F1A51A83" xlink:type="arc" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_A25BFCA1E3BD5D3B9E1D4981F1A51A83" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_CF2F3A7E7BCA564B8BC556D6865C25BE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_9A94C148FC335493A88FFE9FD3265777" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_A25BFCA1E3BD5D3B9E1D4981F1A51A83" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_9A94C148FC335493A88FFE9FD3265777" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/GoodwillAndIntangibleAssetsGrossCarryingAmountsAndNetBookValuesOfIntangibleAssetsDetailsCalc2" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_1969708C4E7F21B4BB696749D036D066_15F93D5ABEB152AA8E00334873E46DB2" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_1969708C4E7F21B4BB696749D036D066_CD6B3C018859516BABA348A9D73D6A06" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_1969708C4E7F21B4BB696749D036D066_15F93D5ABEB152AA8E00334873E46DB2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_1969708C4E7F21B4BB696749D036D066_CD6B3C018859516BABA348A9D73D6A06" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_1969708C4E7F21B4BB696749D036D066_9A94C148FC335493A88FFE9FD3265777" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_1969708C4E7F21B4BB696749D036D066_15F93D5ABEB152AA8E00334873E46DB2" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_1969708C4E7F21B4BB696749D036D066_9A94C148FC335493A88FFE9FD3265777" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/GoodwillAndIntangibleAssetsNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/GoodwillAndIntangibleAssetsTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/IncomeTaxes" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/Inventories" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/InventoriesComponentsOfInventoriesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_0C56D5F2F3695309AACD12CC1DC351D5" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_7373737F3EFE599892A634A2BD1FB815" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_0C56D5F2F3695309AACD12CC1DC351D5" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_7373737F3EFE599892A634A2BD1FB815" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_D8DE40298B6356A1ACDA0FC3397E06B3" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_0C56D5F2F3695309AACD12CC1DC351D5" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_D8DE40298B6356A1ACDA0FC3397E06B3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_72BE3B5353455B75B63847C6D83AD1FF" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_0C56D5F2F3695309AACD12CC1DC351D5" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_72BE3B5353455B75B63847C6D83AD1FF" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/InventoriesTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/Leases" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/LeasesLeaseCostDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeaseCost" xlink:label="loc_us-gaap_LeaseCost_4FB5EFAB1ADB54D8B1C7FB8C9A9C3467" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseCost" xlink:label="loc_us-gaap_OperatingLeaseCost_A775A074326F5694A903012AA02BF464" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_4FB5EFAB1ADB54D8B1C7FB8C9A9C3467" xlink:to="loc_us-gaap_OperatingLeaseCost_A775A074326F5694A903012AA02BF464" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermLeaseCost" xlink:label="loc_us-gaap_ShortTermLeaseCost_EA343BC4082657DCB6393C5730CD776C" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_4FB5EFAB1ADB54D8B1C7FB8C9A9C3467" xlink:to="loc_us-gaap_ShortTermLeaseCost_EA343BC4082657DCB6393C5730CD776C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableLeaseCost" xlink:label="loc_us-gaap_VariableLeaseCost_9028F665763F5D2AAA948D14217EA456" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_4FB5EFAB1ADB54D8B1C7FB8C9A9C3467" xlink:to="loc_us-gaap_VariableLeaseCost_9028F665763F5D2AAA948D14217EA456" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubleaseIncome" xlink:label="loc_us-gaap_SubleaseIncome_42BDC97233AC5A8182052DC5C97AA812" xlink:type="locator" />
    <link:calculationArc order="4" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_4FB5EFAB1ADB54D8B1C7FB8C9A9C3467" xlink:to="loc_us-gaap_SubleaseIncome_42BDC97233AC5A8182052DC5C97AA812" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_3283772D0ED1592F808F35A20B1886DB" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_43D57AA79AFD5855AC761793F98A0B3B" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_3283772D0ED1592F808F35A20B1886DB" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_43D57AA79AFD5855AC761793F98A0B3B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_D1786E3A41955DB984C8E156E816D331" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_3283772D0ED1592F808F35A20B1886DB" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_D1786E3A41955DB984C8E156E816D331" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0DF55031B8295CECB511705690AD403F" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_3283772D0ED1592F808F35A20B1886DB" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0DF55031B8295CECB511705690AD403F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_4E806FA22693514C8D6CFDA7FEEED358" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_3283772D0ED1592F808F35A20B1886DB" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_4E806FA22693514C8D6CFDA7FEEED358" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_C59277F78659537FB2D4EF89218506EF" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_3283772D0ED1592F808F35A20B1886DB" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_C59277F78659537FB2D4EF89218506EF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_76114228EEA353F8A0C683529F1F4175" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_3283772D0ED1592F808F35A20B1886DB" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_76114228EEA353F8A0C683529F1F4175" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetailsCalc2" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_01D76E40802C4756CA536749CFD6D4C9_3283772D0ED1592F808F35A20B1886DB" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_01D76E40802C4756CA536749CFD6D4C9_76924497B2E45D598BBEF1B75BE30D84" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_01D76E40802C4756CA536749CFD6D4C9_3283772D0ED1592F808F35A20B1886DB" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_01D76E40802C4756CA536749CFD6D4C9_76924497B2E45D598BBEF1B75BE30D84" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_01D76E40802C4756CA536749CFD6D4C9_93C12F1B8017549BA80D001E5899FA96" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_01D76E40802C4756CA536749CFD6D4C9_3283772D0ED1592F808F35A20B1886DB" xlink:to="loc_us-gaap_OperatingLeaseLiability_01D76E40802C4756CA536749CFD6D4C9_93C12F1B8017549BA80D001E5899FA96" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_93C12F1B8017549BA80D001E5899FA96" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_9885944CCAB85FC084E8AA342F1948FC" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_93C12F1B8017549BA80D001E5899FA96" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_9885944CCAB85FC084E8AA342F1948FC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_815EB2430A91582AADDDA572A1ED2783" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_93C12F1B8017549BA80D001E5899FA96" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_815EB2430A91582AADDDA572A1ED2783" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/LeasesSupplementalCashFlowInformationDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/LeasesTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/LeasesWeightedAverageTermsAndDiscountRatesDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/NetIncomePerOrdinaryShare" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/NetIncomePerOrdinaryShareBasicAndDilutedNetIncomeLossPerCommonShareDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_72DAB1FA7F0A5E1A9DF366A57A83CF87" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0FDF5297857D5B4E86AE255C60D2F8CB" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_72DAB1FA7F0A5E1A9DF366A57A83CF87" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0FDF5297857D5B4E86AE255C60D2F8CB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_30CF92E1581F55CDB8804B7DC5C9E0D6" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_72DAB1FA7F0A5E1A9DF366A57A83CF87" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_30CF92E1581F55CDB8804B7DC5C9E0D6" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/NetIncomePerOrdinaryShareTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/NetIncomePerOrdinaryShareWeightedAverageOrdinarySharesExcludedFromComputationOfDilutedNetIncomePerShareDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/Revenues" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/RevenuesNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/RevenuesSummaryOfContractLiabilitiesDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/RevenuesSummaryOfDisaggregationOfRevenueDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/RevenuesSummaryOfPercentageOfTotalRevenuesFromCustomersDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/RevenuesTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/ShareBasedCompensation" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/ShareBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_BF269192C0E457A3A4869D585DF874BE" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_6B2D8DACEB7553D6A947B76515E4959B" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_BF269192C0E457A3A4869D585DF874BE" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_6B2D8DACEB7553D6A947B76515E4959B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_8B5457B2D5455F13A69768A0A53C0971" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_BF269192C0E457A3A4869D585DF874BE" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_8B5457B2D5455F13A69768A0A53C0971" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/ShareBasedCompensationRestrictedUnitsDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/ShareBasedCompensationTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/ShareBasedCompensationWeightedAverageAssumptionsAndResultingGrantDateFairValueDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/ShareholdersEquity" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/ShareholdersEquityComponentOfAccumulatedOtherComprehensiveLossDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_5e0cb0dc-b25c-aaae-62f8-cb90f31a16a1" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_58b76f41-3f9e-d766-b689-c2b6aebb7eda" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_5e0cb0dc-b25c-aaae-62f8-cb90f31a16a1" xlink:to="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_58b76f41-3f9e-d766-b689-c2b6aebb7eda" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_e65d9f5e-a3fd-2fc8-3ef3-eaaec4ec01a5" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_5e0cb0dc-b25c-aaae-62f8-cb90f31a16a1" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_e65d9f5e-a3fd-2fc8-3ef3-eaaec4ec01a5" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/ShareholdersEquityShareRepurchaseProgramsDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/ShareholdersEquityTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/SubsequentEvent" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/SubsequentEventNarrativeDetails" xlink:type="extended" />
</link:linkbase>
